| 1 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision | World Journal of Biological Psychiatry | 2008 | 478 |
| 2 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance | World Journal of Biological Psychiatry | 2012 | 459 |
| 3 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders | World Journal of Biological Psychiatry | 2013 | 447 |
| 4 | Serum and plasma BDNF levels in major depression: A replication study and meta-analyses | World Journal of Biological Psychiatry | 2010 | 340 |
| 5 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects | World Journal of Biological Psychiatry | 2013 | 305 |
| 6 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder | World Journal of Biological Psychiatry | 2013 | 290 |
| 7 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care | World Journal of Biological Psychiatry | 2007 | 271 |
| 8 | The suicidal mind and brain: A review of neuropsychological and neuroimaging studies | World Journal of Biological Psychiatry | 2011 | 262 |
| 9 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression | World Journal of Biological Psychiatry | 2010 | 257 |
| 10 | Tinnitus and depression | World Journal of Biological Psychiatry | 2011 | 230 |
| 11 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder | World Journal of Biological Psychiatry | 2002 | 226 |
| 12 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania | World Journal of Biological Psychiatry | 2009 | 225 |
| 13 | Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition | World Journal of Biological Psychiatry | 2017 | 213 |
| 14 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia | World Journal of Biological Psychiatry | 2005 | 208 |
| 15 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry | World Journal of Biological Psychiatry | 2018 | 206 |
| 16 | Assessment and management of agitation in psychiatry: Expert consensus | World Journal of Biological Psychiatry | 2016 | 190 |
| 17 | Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression | World Journal of Biological Psychiatry | 2007 | 188 |
| 18 | The Tutsi genocide and transgenerational transmission of maternal stress: epigenetics and biology of the HPA axis | World Journal of Biological Psychiatry | 2014 | 188 |
| 19 | Melatonin in mood disorders | World Journal of Biological Psychiatry | 2006 | 183 |
| 20 | Management of mild cognitive impairment (MCI): The need for national and international guidelines | World Journal of Biological Psychiatry | 2020 | 171 |
| 21 | Set-shifting abilities, central coherence, and handedness in anorexia nervosa patients, their unaffected siblings and healthy controls: Exploring putative endophenotypes | World Journal of Biological Psychiatry | 2010 | 170 |
| 22 | Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics | World Journal of Biological Psychiatry | 2016 | 162 |
| 23 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia | World Journal of Biological Psychiatry | 2006 | 161 |
| 24 | Central coherence in eating disorders: An updated systematic review and meta-analysis | World Journal of Biological Psychiatry | 2014 | 160 |
| 25 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias | World Journal of Biological Psychiatry | 2010 | 148 |
| 26 | Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce | World Journal of Biological Psychiatry | 2022 | 147 |
| 27 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015 | World Journal of Biological Psychiatry | 2015 | 143 |
| 28 | Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity | World Journal of Biological Psychiatry | 2014 | 139 |
| 29 | Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: A meta-analysis and systematic review | World Journal of Biological Psychiatry | 2020 | 139 |
| 30 | Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders | World Journal of Biological Psychiatry | 2013 | 137 |
| 31 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder | World Journal of Biological Psychiatry | 2018 | 133 |
| 32 | Social reward and rejection sensitivity in eating disorders: An investigation of attentional bias and early experiences | World Journal of Biological Psychiatry | 2013 | 131 |
| 33 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders | World Journal of Biological Psychiatry | 2011 | 129 |
| 34 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders | World Journal of Biological Psychiatry | 2002 | 123 |
| 35 | The insular Lobe of Reil–its Anatamico-Functional, behavioural and Neuropsychiatric attributes in humans–a review | World Journal of Biological Psychiatry | 2004 | 123 |
| 36 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorders, Part I: Treatment of Bipolar Depression | World Journal of Biological Psychiatry | 2002 | 122 |
| 37 | The World Federation of Socleties of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania | World Journal of Biological Psychiatry | 2003 | 120 |
| 38 | Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity | World Journal of Biological Psychiatry | 2012 | 120 |
| 39 | Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice | World Journal of Biological Psychiatry | 2019 | 116 |
| 40 | Sleep disturbances: Core symptoms of major depressive disorder rather than associated or comorbid disorders | World Journal of Biological Psychiatry | 2009 | 115 |
| 41 | Abnormal body perception and neural activity in the insula in depression: An fMRI study of the depressed “material me” | World Journal of Biological Psychiatry | 2010 | 114 |
| 42 | The biology of burnout: Causes and consequences | World Journal of Biological Psychiatry | 2021 | 113 |
| 43 | Pro-inflammatory biomakers in depression: Treatment with venlafaxine | World Journal of Biological Psychiatry | 2009 | 112 |
| 44 | Resting-state network dysconnectivity in ADHD: A system-neuroscience-based meta-analysis | World Journal of Biological Psychiatry | 2020 | 111 |
| 45 | Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: Impact of past episodes | World Journal of Biological Psychiatry | 2006 | 108 |
| 46 | Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment | World Journal of Biological Psychiatry | 2010 | 107 |
| 47 | Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications | World Journal of Biological Psychiatry | 2001 | 105 |
| 48 | TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians | World Journal of Biological Psychiatry | 2018 | 104 |
| 49 | Brain iron levels in attention-deficit/hyperactivity disorder: A pilot MRI study | World Journal of Biological Psychiatry | 2012 | 103 |
| 50 | Thyroid Hormone, Neural Tissue and Mood Modulation | World Journal of Biological Psychiatry | 2001 | 102 |